◆ NeutralCOPLCOPL.UCOPL.WS

Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology

GlobeNewswire Inc.·
Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology

Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics have announced a definitive business combination agreement. Upon closing, the companies will form Ignite Proteomics Holdings, Inc. (PubCo), to be listed on the NYSE. The transaction values Ignite at a $150 million pro forma enterprise value and is expected to close in the second half of 2026. Ignite Proteomics specializes in pathway-level protein analytics for precision oncology.

Read Full Article at GlobeNewswire Inc.
← Back to Financial Intelligence